Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,937 | 61,666 | 50,950 | 50,023 | 35,339 |
| Marketable Securities | N/A | 35,000 | 43,641 | 27,034 | 57,658 |
| Receivables | 104,791 | 81,389 | 79,301 | 84,473 | 81,916 |
| Inventories | 106,373 | 95,996 | 93,242 | 85,540 | 81,229 |
| Income taxes - deferred | 21,125 | 16,884 | 13,967 | 15,180 | 14,293 |
| Other current assets | 10,530 | 11,328 | 10,793 | 9,544 | 10,524 |
| TOTAL | $296,756 | $302,263 | $291,894 | $271,794 | $280,959 |
| Non-Current Assets | |||||
| PPE Net | 108,796 | 99,628 | 91,165 | 88,795 | 67,273 |
| Intangibles | 0 | 157,669 | 0 | 0 | 0 |
| Other Non-Current Assets | 240,942 | 0 | 141,913 | 140,789 | 127,010 |
| TOTAL | $349,738 | $257,297 | $233,078 | $229,584 | $194,283 |
| Total Assets | $646,494 | $559,560 | $524,972 | $501,378 | $475,242 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,313 | 678 | 665 | N/A | N/A |
| Accounts payable and accrued liabilities | 27,316 | 24,374 | 23,193 | 24,240 | 25,034 |
| Accrued Expenses | 73,620 | 72,250 | 67,335 | 65,280 | 51,051 |
| TOTAL | $188,415 | $124,743 | $116,732 | $123,321 | $98,368 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,271 | 6,447 | 6,625 | 6,795 | N/A |
| Deferred Revenues | 9,235 | 8,976 | 8,440 | 8,950 | 8,301 |
| Other Non-Current Liabilities | 18,069 | 4,521 | 1,737 | 1,957 | 959 |
| TOTAL | $45,995 | $24,956 | $20,655 | $21,023 | $13,815 |
| Total Liabilities | $234,410 | $149,699 | $137,387 | $144,344 | $112,183 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,909 | 124,554 | 125,195 | 124,582 | 126,225 |
| Common Shares | 4,688 | 9,324 | 4,656 | 4,638 | 4,628 |
| Retained earnings | 512,875 | 490,614 | 465,942 | 440,989 | 415,209 |
| Other shareholders' equity | 14,117 | 12,592 | 8,447 | 5,209 | 2,559 |
| TOTAL | $412,084 | $409,861 | $387,585 | $357,034 | $363,059 |
| Total Liabilities And Equity | $646,494 | $559,560 | $524,972 | $501,378 | $475,242 |